Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02333617 · ClinicalTrials.gov registry record · NA

Manual Therapy to Treat Gluteus Medius Trigger Points

A NA study, sponsored by Mitchell Selhorst.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT02333617: Clinical Trial NA study, sponsored by Mitchell Selhorst.

NCT02333617 is a NA study that was terminated before completion, run by Mitchell Selhorst. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02333617, a NA study, was terminated before completion, sponsored by Mitchell Selhorst.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

This is a blinded randomized controlled trial to assess the effectiveness of manual therapy to improve hip abduction strength in patients with acute anterior knee pain. The primary objective of this study is to see if manual therapy to the gluteus medius can significantly alter within-session measurements of hip abductor strength in patients with anterior knee pain. The secondary objective of this study is to see if manual therapy to the gluteus medius can significantly alter within session pain in patients with anterior knee pain.

Primary Outcome

Isometric maximal voluntary contraction strength of the hip abductor muscles will be measured with a portable dynamometer. The dynamometer is placed so as the testing pad is positioned 5cm proximal to the lateral femoral condyle. Two to three maximal voluntary contraction trials will be permitted. The subjects will be instructed to produce their maximal force without any concern for the rate of force development. The duration of these contractions will be 5 seconds, and thirty seconds of rest w

Interventions

  • OTHER Placebo Control
  • OTHER Dry Needling
  • OTHER Soft Tissue Mobilization
  • OTHER Hip and core strengthening exercises

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2015-01
Est. Completion 2017-12
Phase NA
Mitchell Selhorst

3 total trials

Why NCT02333617 stopped before completion

NCT02333617 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 4 interventions - of which Placebo Control is the first listed.

NCT02333617 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02333617 about?

NCT02333617 is a clinical study titled "Manual Therapy to Treat Gluteus Medius Trigger Points". This is a blinded randomized controlled trial to assess the effectiveness of manual therapy to improve hip abduction strength in patients with acute anterior knee pain. The primary objective of this study is to see if manual therapy to the gluteus medius can significantly alter within-session measu...

What is the current status of trial NCT02333617?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2015-01. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02333617?

The interventions under investigation include: Placebo Control (OTHER), Dry Needling (OTHER), Soft Tissue Mobilization (OTHER), Hip and core strengthening exercises (OTHER).

Who is sponsoring clinical trial NCT02333617?

This trial is sponsored by Mitchell Selhorst, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02333617's enrollment target sits among peer trials

3 1996th of 2000 higher than 4 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02333617, the US trial registry maintained by the National Library of Medicine. NCT02333617 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.